Article | April 26, 2021

Choice And Control: Data Sharing With Connected Clinical Trials

By Jason Methia, Vice President, Veeva Site Connect, Veeva Systems, Inc.

Veeva

[SURVEY] Complete the Digital Clinical Trials Survey and help the industry better understand our move towards decentralized trials.

Long before the COVID-19 pandemic, legacy processes for data sharing and collaboration were called out as key barriers to modernizing clinical trials. More recently, the global pandemic accelerated the adoption of new technologies to run clinical trial processes, pushing the industry to address the fundamental challenges surrounding how information is shared across sponsors, CROs, and clinical research sites.

While progress has been made to advance the industry towards more digital ways of working, concerns around data privacy and security are top of mind, particularly in the context of systems that are used to share study documents and site staff information that may contain personal data with sponsors and CROs. The need to safeguard what information is shared – and with whom – is more important today than ever before, especially as the industry moves toward a digitally connected clinical trial environment.

Read why choice, control, and transparency are key in site/sponsor collaboration.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: